|
1
|
Shi X, Zhu HR, Liu TT, Shen XZ and Zhu JM:
The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in
action. Cancer Lett. 400:175–182. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fujiwara N, Friedman SL, Goossens N and
Hoshida Y: Risk factors and prevention of hepatocellular carcinoma
in the era of precision medicine. J Hepatol. 68:526–549. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma M, Cai B, Jiang L, Abdalla BA, Li Z,
Nie Q and Zhang X: lncRNA-Six1 Is a target of miR-1611 that
functions as a ceRNA to regulate six1 protein expression and fiber
type switching in chicken myogenesis. Cells. 7(pii): E2432018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu Y, Bian Y, Zhang Q, Hu J, Li L, Yang
M, Qian H, Yu L, Liu B and Qian X: Construction and analysis of
dysregulated lncRNA-associated ceRNA network in colorectal cancer.
J Cell Biochem. Dec 7–2018.(Epub ahead of print).
|
|
9
|
Jiang N, Wang X, Xie X, Liao Y, Liu N, Liu
J, Miao N, Shen J and Peng T: lncRNA DANCR promotes tumor
progression and cancer stemness features in osteosarcoma by
upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 405:46–55.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li W, Jia G, Qu Y, Du Q and Liu B and Liu
B: Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer
invasion and metastasis by regulating epithelial-mesenchymal
transition. Med Sci Monit. 23:3393–3403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu B, Cai H, Zheng R, Yang S, Zhou Z and
Tu J: Long non-coding RNA 657 suppresses hepatocellular carcinoma
cell growth by acting as a molecular sponge of miR-106a-5p to
regulate PTEN expression. Int J Biochem Cell Biol. 92:34–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mineo M, Ricklefs F, Rooj AK, Lyons SM,
Ivanov P, Ansari KI, Nakano I, Chiocca EA, Godlewski J and Bronisz
A: The long non-coding RNA HIF1A-AS2 facilitates the maintenance of
mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell
Rep. 15:2500–2509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang HY, Zheng FS, Yang W and Lu JB: The
long non-coding RNA MIAT regulates zinc finger E-box binding
homeobox 1 expression by sponging miR-150 and promoteing cell
invasion in non-small-cell lung cancer. Gene. 633:61–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li XL, Subramanian M, Jones MF, Chaudhary
R, Singh DK, Zong X, Gryder B, Sindri S, Mo M, Schetter A, et al:
Long noncoding RNA PURPL suppresses basal p53 levels and promotes
tumorigenicity in colorectal cancer. Cell Rep. 20:2408–2423. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu
SJ, Xiao CC, Jia CC and Fu BS: Downregulation of miR-542-3p
promotes cancer metastasis through activating TGF-β/Smad signaling
in hepatocellular carcinoma. Onco Targets Ther. 11:1929–1939. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin
X and Cheng Y: MicroRNA-655-3p functions as a tumor suppressor by
regulating ADAM10 and β-catenin pathway in Hepatocellular
Carcinoma. J Exp Clin Cancer Res. 35:892016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lohitesh K, Chowdhury R and Mukherjee S:
Resistance a major hindrance to chemotherapy in hepatocellular
carcinoma: An insight. Cancer Cell Int. 18:442018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Chen F, Zhao M, Yang Z, Li J,
Zhang S, Zhang W, Ye L and Zhang X: The long noncoding RNA HULC
promotes liver cancer by increasing the expression of the HMGA2
oncogene via sequestration of the microRNA-186. J Biol Chem.
292:15395–15407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J: Long noncoding RNA TSLNC8 is a
tumor suppressor that inactivates the interleukin-6/STAT3 signaling
pathway. Hepatology. 67:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Yang Y, Wang T, Wang L, Wang X, Li
T, Shi Y and Wang Y: Long non-coding RNA CCAL promotes
hepatocellular carcinoma progression by regulating AP-2α and
Wnt/β-catenin pathway. Int J Biol Macromol. 109:424–434. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vousden KH and Lu X: Live or let die: The
cell's response to p53. Nat Rev Cancer. 2:594–604. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu H, Wang J, Yin J, Lu B, Yang Q, Wan Y
and Jia C: Downregulation of PRAME suppresses proliferation and
promotes apoptosis in hepatocellular carcinoma through the
activation of P53 mediated pathway. Cell Physiol Biochem.
45:1121–1135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng X, Franklin DA, Dong J and Zhang Y:
MDM2-p53 pathway in hepatocellular carcinoma. Cancer Res.
74:7161–7167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Su P, Wang F, Qi B, Wang T and Zhang S:
P53 Regulation-association long non-coding RNA (LncRNA PRAL)
inhibits cell proliferation by regulation of P53 in human lung
cancer. Med Sci Monit. 23:1751–1758. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pollutri D, Gramantieri L, Bolondi L and
Fornari F: TP53/MicroRNA interplay in hepatocellular carcinoma. Int
J Mol Sci. 17(pii): E20292016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J, Rao J, Lou X, Zhai J, Ni Z and Wang
X: Upregulated TRIM11 exerts its oncogenic effects in
hepatocellular carcinoma through inhibition of P53. Cell Physiol
Biochem. 44:255–266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou CC, Yang F, Yuan SX, Ma JZ, Liu F,
Yuan JH, Bi FR, Lin KY, Yin JH, Cao GW, et al: Systemic genome
screening identifies the outcome associated focal loss of long
noncoding RNA PRAL in hepatocellular carcinoma. Hepatology.
63:850–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren Y, Shang J, Li J, Liu W, Zhang Z, Yuan
J and Yang M: The long noncoding RNA PCAT-1 links the microRNA
miR-215 to oncogene CRKL-mediated signaling in hepatocellular
carcinoma. J Biol Chem. 292:17939–17949. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang M, Wang W, Li T, Yu X, Zhu Y, Ding
F, Li D and Yang T: Long noncoding RNA SNHG1 predicts a poor
prognosis and promotes hepatocellular carcinoma tumorigenesis.
Biomed Pharmacother. 80:73–79. 2016. View Article : Google Scholar : PubMed/NCBI
|
